Selenium (Se) is an essential trace element in human nutrition due to its presence, in the form of selenocysteine residue, in 25 selenoproteins. Selenoproteins participate in diverse biological processes, but their key roles are to regulate cellular redox homeostasis. These redox activities are modulated by the level and chemical form of dietary Se in a selenoprotein- and organ-specific manner. Selenoprotein status has been implicated in a variety of physiological processes and diseases, but the function of Se that attracted the most attention is its role in cancer. There are numerous studies, including clinical trials, which support the role of Se in cancer prevention, but there are also studies that found no such role. The consensus is that Se may be beneficial under conditions of low Se status, when selenoprotein levels are suboptimal, whereas this micronutrient is not effective in cancer prevention when Se levels are above that needed to saturate selenoprotein expression. Our research revealed a dual role the 15 kDa selenoprotein (Sep15) in cancer. We hypothesize that Sep15 and its homolog selenoprotein M (SelM) serve as redox gatekeepers for disulfide-rich proteins that pass through the endoplasmic reticulum. This hypothesis will be addressed using cell culture and mouse models. We will determine redox targets of Sep15 and SelM, characterize consequences of their deficiency, profile immunoglobulins in selenoprotein knockout mice and examine their maturation status. In addition, we found that high-throughput analyses of selenoproteins in a large panel of human cancer cell lines provides direct insights into the functions of these proteins in the context of human cancer, control of redox homeostasis and dependence of various cancer types on selenoproteins. We will characterize the human selenoproteome and selenocysteine machinery for their roles in human cancer by analyzing coexpression patterns and dependence of various cancer types on selenoproteins and drugs, and will link this information with genotype and expression patterns. This information will define the roles of selenoproteins in human cancer and provide critical information for the development of approaches for personalized use of dietary selenium to modulate cancer prevention and progression. Overall, these studies will provide critical insights into the role of selenium and selenoproteins in cancer.
Mechanisms by which the trace element selenium affects cancer incidence are not known. We propose to functionally characterize selenoproteins that are thought to mediate the effect of selenium in cancer prevention and progression. We will also examine selenoprotein functions and regulation in the context of human cancer.
|Podolskiy, Dmitriy I; Lobanov, Alexei V; Kryukov, Gregory V et al. (2016) Analysis of cancer genomes reveals basic features of human aging and its role in cancer development. Nat Commun 7:12157|
|Podolskiy, Dmitriy I; Gladyshev, Vadim N (2016) Intrinsic Versus Extrinsic Cancer Risk Factors and Aging. Trends Mol Med 22:833-834|
|Mariotti, Marco; Lobanov, Alexei V; Manta, Bruno et al. (2016) Lokiarchaeota Marks the Transition between the Archaeal and Eukaryotic Selenocysteine Encoding Systems. Mol Biol Evol 33:2441-53|
|Tobe, Ryuta; Carlson, Bradley A; Huh, Jang Hoe et al. (2016) Selenophosphate synthetase 1 is an essential protein with roles in regulation of redox homoeostasis in mammals. Biochem J 473:2141-54|
|Tian, Xiao; Azpurua, Jorge; Ke, Zhonghe et al. (2015) INK4 locus of the tumor-resistant rodent, the naked mole rat, expresses a functional p15/p16 hybrid isoform. Proc Natl Acad Sci U S A 112:1053-8|
|Ma, Siming; Lee, Sang-Goo; Kim, Eun Bae et al. (2015) Organization of the Mammalian Ionome According to Organ Origin, Lineage Specialization, and Longevity. Cell Rep 13:1319-26|
|Tobe, Ryuta; Carlson, Bradley A; Tsuji, Petra A et al. (2015) Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for Therapy. Cancers (Basel) 7:2262-76|
|Bang, Jeyoung; Huh, Jang Hoe; Na, Ji-Woon et al. (2015) Cell Proliferation and Motility Are Inhibited by G1 Phase Arrest in 15-kDa Selenoprotein-Deficient Chang Liver Cells. Mol Cells 38:457-65|
|Cornelis, Marilyn C; Fornage, Myriam; Foy, Millennia et al. (2015) Genome-wide association study of selenium concentrations. Hum Mol Genet 24:1469-77|
|Tsuji, Petra A; Carlson, Bradley A; Yoo, Min-Hyuk et al. (2015) The 15kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways. PLoS One 10:e0124487|
Showing the most recent 10 out of 56 publications